Patent 7550457 was granted and assigned to CytRx on June, 2009 by the United States Patent and Trademark Office.
The subject invention relates to carboxamidine derivatives, to pharmaceutical compositions containing the carboxamidine derivatives of the invention, and the use thereof for the treatment of vascular diseases and in the preparation of pharmaceutical compositions for the treatment of vascular diseases.